237 related articles for article (PubMed ID: 35419917)
1. Overexpression of FOXD2-AS1 enhances proliferation and impairs differentiation of glioma stem cells by activating the NOTCH pathway via TAF-1.
Wang Y; Cheng Y; Yang Q; Kuang L; Liu G
J Cell Mol Med; 2022 May; 26(9):2620-2632. PubMed ID: 35419917
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR-185-5p/CCND2 axis.
Shen F; Chang H; Gao G; Zhang B; Li X; Jin B
J Cell Biochem; 2019 Jun; 120(6):9324-9336. PubMed ID: 30520141
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1.
Dong H; Cao W; Xue J
Biochem Biophys Res Commun; 2019 Jan; 508(4):1074-1081. PubMed ID: 30553445
[TBL] [Abstract][Full Text] [Related]
4. FoxD2-AS1 promotes glioma progression by regulating miR-185-5P/HMGA2 axis and PI3K/AKT signaling pathway.
Ni W; Xia Y; Bi Y; Wen F; Hu D; Luo L
Aging (Albany NY); 2019 Mar; 11(5):1427-1439. PubMed ID: 30860979
[TBL] [Abstract][Full Text] [Related]
5. Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis.
Gu N; Wang X; Di Z; Xiong J; Ma Y; Yan Y; Qian Y; Zhang Q; Yu J
Aging (Albany NY); 2019 Nov; 11(22):10266-10283. PubMed ID: 31770107
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA FOXD2-AS1 promotes glioma cell cycle progression and proliferation through the FOXD2-AS1/miR-31/CDK1 pathway.
Wang J; Li B; Wang C; Luo Y; Zhao M; Chen P
J Cell Biochem; 2019 Dec; 120(12):19784-19795. PubMed ID: 31347720
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of lncRNA FOXD2-AS1 Confers Radiosensitivity to Gastric Cancer Cells via miR-1913/SETD1A Axis.
Guo F; Guo R; Zhang L
Cytogenet Genome Res; 2022; 162(1-2):10-27. PubMed ID: 35354145
[TBL] [Abstract][Full Text] [Related]
8. Silencing of long non-coding RNA FOXD2-AS1 inhibits the progression of gallbladder cancer by mediating methylation of MLH1.
Gao J; Dai C; Yu X; Yin XB; Liao WJ; Huang Y; Zhou F
Gene Ther; 2021 Jun; 28(6):306-318. PubMed ID: 32917950
[TBL] [Abstract][Full Text] [Related]
9. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
Lei T; Zhu X; Zhu K; Jia F; Li S
Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
[TBL] [Abstract][Full Text] [Related]
10. Silence of FOXD2-AS1 inhibited the proliferation and invasion of esophagus cells by regulating miR-145-5p/CDK6 axis.
Shi W; Gao Z; Song J; Wang W
Histol Histopathol; 2020 Sep; 35(9):1013-1021. PubMed ID: 32524576
[TBL] [Abstract][Full Text] [Related]
11. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression.
Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022
[TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA (lncRNA) FOXD2-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Regulating MiR-185/AKT Axis.
Chen Z; Zhang Z; Zhao D; Feng W; Meng F; Han S; Lin B; Shi X
Med Sci Monit; 2019 Dec; 25():9618-9629. PubMed ID: 31841454
[TBL] [Abstract][Full Text] [Related]
13. LncRNA FOXD2-AS1 stimulates glioma progression through inhibiting P53.
Zhao QS; Ying JB; Jing JJ; Wang SS
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4382-4388. PubMed ID: 32373975
[TBL] [Abstract][Full Text] [Related]
14. Long Non-coding RNA FOXD2-AS1 Promotes Proliferation, Migration, and Invasion in Cholangiocarcinoma Through Regulating miR-760/E2F3 Axis.
Hu Z; Huang L; Wang W; Guan C; Zhao Y; Liu L; Jiang X
Dig Dis Sci; 2022 Feb; 67(2):546-558. PubMed ID: 33570683
[TBL] [Abstract][Full Text] [Related]
15. Induction of cancer cell stemness in glioma through glycolysis and the long noncoding RNA HULC-activated FOXM1/AGR2/HIF-1α axis.
Li YP; Liu Y; Xiao LM; Chen LK; Tao EX; Zeng EM; Xu CH
Lab Invest; 2022 Jul; 102(7):691-701. PubMed ID: 35013529
[TBL] [Abstract][Full Text] [Related]
16. FOXD2-AS1 acts an oncogene in esophageal squamous cell carcinoma through sponging miR-204-3p.
Luo D; Salai A; Lv H; Wang Y; Gao Y
Clin Transl Oncol; 2022 Oct; 24(10):1954-1963. PubMed ID: 35778646
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of lncRNA FOXD2-AS1 Inhibits Proliferation, Migration, and Drug Resistance of Breast Cancer Cells.
Nong Q; Yu S; Hu H; Hu X
Comput Math Methods Med; 2021; 2021():9674761. PubMed ID: 34873418
[TBL] [Abstract][Full Text] [Related]
18. LncRNA FOXD2-AS1 regulates chondrocyte proliferation in osteoarthritis by acting as a sponge of miR-206 to modulate CCND1 expression.
Cao L; Wang Y; Wang Q; Huang J
Biomed Pharmacother; 2018 Oct; 106():1220-1226. PubMed ID: 30119190
[TBL] [Abstract][Full Text] [Related]
19. lncRNA FOXD2-AS1 Promotes the Retinoblastoma Cell Viability and Migration by Sponging miR-31.
Liang Y; Wang H; Song R; Yin X
Biomed Res Int; 2022; 2022():7723425. PubMed ID: 35782084
[TBL] [Abstract][Full Text] [Related]
20. LncRNA FOXD2-AS1 as a competitive endogenous RNA against miR-150-5p reverses resistance to sorafenib in hepatocellular carcinoma.
Sui C; Dong Z; Yang C; Zhang M; Dai B; Geng L; Lu J; Yang J; Xu M
J Cell Mol Med; 2019 Sep; 23(9):6024-6033. PubMed ID: 31210410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
